Article
Noncanonical mutations in ribosome nascent peptide exit tunnel confer clarithromycin resistance in Mycobacterium abscessus complex.
International journal of antimicrobial agents - 1 Aug 2024
Liao Wei, Wang Xinyan, Wang Yi, Ma Pengjiao, Chen Ken, Ge Liang, Yang Xiaoyan, Zeng Shushu, Gao Wenfeng, Zhang Shu, Wang Hongren, Jia Xu, Luo Tao
Abstract excerpt
OBJECTIVES: Mycobacterium abscessus is a non-tuberculous mycobacterial pathogen that causes pulmonary and skin infections globally. Clarithromycin plays a pivotal role in treating M. abscessus infections, with resistance often leading to treatment failure. While canonical mutations in the 23S rRNA residue 2270/2271 are recognized as the primary mechanism for acquired clarithromycin resistance, resistant isolates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
